Related Experiment Video
Updated: Sep 25, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Long pentraxin 3 as a marker of COVID-19 severity: evidences and perspectives
Roberto Assandri1, Silvia Accordino2, Ciro Canetta2
1Clinical Investigation Laboratory, Ospedale Maggiore di Crema, Crema, Italy.
Insights
High levels of Pentraxin 3 (PTX3) accurately predict severe Coronavirus Disease 2019 (COVID-19) and the need for intensive care unit (ICU) admission. PTX3 is a more reliable indicator than standard laboratory tests.
Area of Science:
- Biochemistry
- Immunology
- Critical Care Medicine
Background:
- Coronavirus Disease 2019 (COVID-19) presents with varied laboratory abnormalities, often insufficient for predicting disease severity.
- The long pentraxin 3 (PTX3) is an inflammatory marker released at inflammation sites, previously linked to severity in other inflammatory conditions.
Purpose of the Study:
- To evaluate Pentraxin 3 (PTX3) as a predictive marker for COVID-19 severity.
- To compare the efficacy of PTX3 in identifying severe COVID-19 cases against routine laboratory parameters.
Main Methods:
- Retrospective analysis of serum samples from RT-PCR confirmed COVID-19 patients at hospital admission.
- Measurement of Pentraxin 3 (PTX3) using enzyme-linked immunosorbent assay (ELISA).
- Intensive care unit (ICU) stay was used as a surrogate endpoint for severe COVID-19.
Main Results:
- Pentraxin 3 (PTX3) levels were significantly higher in ICU patients compared to non-ICU patients (35.86 vs. 10.61 ng/mL, P < 0.001).
- PTX3 was the sole significant laboratory predictor of ICU stay in multivariate analysis (OR: 1.68, P = 0.003).
- PTX3 demonstrated superior accuracy (AUC = 0.98) in identifying ICU patients compared to C-reactive protein (CRP), lactate dehydrogenase (LD), and ferritin.
Conclusions:
- Elevated Pentraxin 3 (PTX3) levels are indicative of severe Coronavirus Disease 2019 (COVID-19).
- PTX3 serves as a highly accurate biomarker for predicting the need for intensive care unit (ICU) admission in COVID-19 patients.
Introduction:
Several laboratory tests are characteristically altered in Coronavirus Disease 2019 (COVID-19), but are not totally accurate in predicting the disease outcome. The long pentraxin 3 (PTX3) is quickly released directly at inflammation sites by many immune cell types. Previous studies have shown that PTX3 correlated with disease severity in various inflammatory conditions. Our study investigated the use of PTX3 as a potential marker of COVID-19 severity and compared its performance in detecting a more severe form of the disease with that of routine laboratory parameters.
Materials And Methods:
Stored serum samples of RT-PCR confirmed COVID-19 cases that had been obtained at hospital admission were retrospectively analysed. Intensive care unit (ICU) stay was considered a surrogate endpoint of severe COVID-19. Pentraxin 3 was measured by a commercial enzyme-linked immunosorbent assay.
Results:
A total of 96 patients were recruited from May 1st, 2020 to June 30th, 2020; 75/96 were transferred to ICU. Pentraxin 3 was higher in ICU vs non-ICU patients (35.86 vs 10.61 ng/mL, P < 0.001). Univariate and multivariate logistic regression models demonstrated that the only significant laboratory predictor of ICU stay was PTX3 (OR: 1.68 (1.19-2.29), P = 0.003), after controlling for comorbidities. The Receiver Operator Characteristic curve analysis showed that PTX3 had a higher accuracy compared to C-reactive protein (CRP), lactate dehydrogenase (LD), ferritin in identifying ICU patients (AUC of PTX3 = 0.98; CRP = 0.66; LD = 0.70; ferritin = 0.67, P < 0.001). A cut-off of PTX3 > 18 ng/mL yielded a sensitivity of 96% and a specificity of 100% in identifying patients requiring ICU.
Conclusion:
High values of PTX3 predict a more severe COVID-19.
More Related Videos
07:18Quantifying Myeloperoxidase-DNA and Neutrophil Elastase-DNA Complexes from Neutrophil Extracellular Traps by Using a Modified Sandwich ELISA
Published on: May 12, 2023
05:28Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
Related Concept Videos
Pneumonia III: Complications and Assessment
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pericarditis II: Clinical Features and Diagnostic Tests
Single Nucleotide Polymorphisms-SNPs
Acute Coronary Syndrome III: Diagnostic Studies
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...